Search research articles
Contact Us
Filters
Showing results (91-100 of 113) with videos related to
Page
of 12
Sort By:
Cancer Immunology, Immunotherapy : CII
|
August 5, 1998
Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors
H K Boxhorn, J G Smith, Y J Chang, et al.
Investigational New Drugs
|
January 1, 1987
Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma
D A Amato, H Bruckner, D Guerry, et al.
Cancer Research
|
November 1, 1985
Characteristics of cultured human melanocytes isolated from different stages of tumor progression
M Herlyn, J Thurin, G Balaban, et al.
Annals of Internal Medicine
|
September 1, 1996
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group
L Schuchter, D J Schultz, M Synnestvedt, et al.
Journal of the National Cancer Institute
|
February 1, 1985
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells
M Herlyn, G Balaban, J Bennicelli, et al.
Journal of Computer Assisted Tomography
|
July 1, 1987
MR imaging of intracranial metastatic melanoma
S W Atlas, R I Grossman, J M Gomori, et al.
Cancer Research
|
November 1, 1983
Phenotypic characteristics of cells derived from precursors of human melanoma
M Herlyn, D Herlyn, D E Elder, et al.
Cancer
|
July 15, 1985
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm)
D E Elder, D Guerry, M VanHorn, et al.
Plastic and Reconstructive Surgery
|
January 1, 1983
Optimal resection margin for cutaneous malignant melanoma
D E Elder, D Guerry, R M Heiberger, et al.
American Journal of Ophthalmology
|
October 15, 1984
Lack of association between intraocular melanoma and cutaneous dysplastic nevi
M R Taylor, D Guerry, E E Bondi, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 113) with videos related to
Sort By:
Page
of 12
Cancer Immunology, Immunotherapy : CII
|
August 5, 1998
Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors
H K Boxhorn, J G Smith, Y J Chang, et al.
Investigational New Drugs
|
January 1, 1987
Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma
D A Amato, H Bruckner, D Guerry, et al.
Cancer Research
|
November 1, 1985
Characteristics of cultured human melanocytes isolated from different stages of tumor progression
M Herlyn, J Thurin, G Balaban, et al.
Annals of Internal Medicine
|
September 1, 1996
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group
L Schuchter, D J Schultz, M Synnestvedt, et al.
Journal of the National Cancer Institute
|
February 1, 1985
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells
M Herlyn, G Balaban, J Bennicelli, et al.
Journal of Computer Assisted Tomography
|
July 1, 1987
MR imaging of intracranial metastatic melanoma
S W Atlas, R I Grossman, J M Gomori, et al.
Cancer Research
|
November 1, 1983
Phenotypic characteristics of cells derived from precursors of human melanoma
M Herlyn, D Herlyn, D E Elder, et al.
Cancer
|
July 15, 1985
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm)
D E Elder, D Guerry, M VanHorn, et al.
Plastic and Reconstructive Surgery
|
January 1, 1983
Optimal resection margin for cutaneous malignant melanoma
D E Elder, D Guerry, R M Heiberger, et al.
American Journal of Ophthalmology
|
October 15, 1984
Lack of association between intraocular melanoma and cutaneous dysplastic nevi
M R Taylor, D Guerry, E E Bondi, et al.
Page
of 12